Artificial Vital Organs & Medical Bionics Market: By Product & By Region - Forecast 2016-2022 - Product Image

Artificial Vital Organs & Medical Bionics Market: By Product & By Region - Forecast 2016-2022

  • ID: 4033551
  • Report
  • 160 pages
  • IndustryARC
1 of 3
Artificial organs can be defined as devices which are integrated or implanted into the human body to replace a natural organ, to restore its specific function in the body, and the medical bionic devices are engineered with a combined study of biology and electronics terminologies. Artificial vital organs and medical bionics are technologically sophisticated devices which help in the restoration of various functions of organs and increase the life expectancy of the patients. Globally, increasing cases of organ failure and lack of donors are expected to be the prime growth factors for artificial vital organs and medical bionics during the period of study.

Geographically, North America dominated the artificial vital organs & medical bionics market driven by world class healthcare infrastructure with technological advanced practice, higher spending and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for artificial vital organs & medical bionics. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

This report identifies the artificial vital organs & medical bionics market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the artificial vital organs & medical bionics market.

This report segments the artificial vital organs & medical bionics market on the basis of product and regional market as follows:
Artificial vital organs & medical bionics market research report is classified on the basis of product. Some of the major product covered in this report are as follows: Artificial Vital Organs Market (Artificial Heart (Total Artificial Heart (TAH)), Artificial Kidney (Hemodialysis Machines), Artificial Liver, Artificial Pancreas (Insulin Pumps), Artificial Lungs (Heart-Lung Bypass Machines, Oxygenators)), Bionics Market (Ear Bionics (Cochlear Implants), Vision Bionics, Exoskeletons, Bionic Limbs (Bionic Leg, Bionic Hand), Brain Bionics (Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators), Cardiac Bionics ( Ventricular Assist Device (VAD), Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD)), Heart Valves (Mechanical Heart Valves, Biological Tissue Valves, Transcatheter Heart Valves)).

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region.

This report identifies all the major companies operating in the artificial vital organs & medical bionics market. Some of the major companies’ profiles in detail are as follows:

Abbott Diabetes Care, Inc.

Asahi Kasei Medical Co., Ltd.

Edwards Lifesciences Corporation
F. Hoffmann-La Roche Ltd
Fresenius Medical Care AG & Co. Kgaa
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Artificial vital organs & medical bionics Market – Overview

2. Executive Summary

3. Artificial vital organs & medical bionics Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Artificial vital organs & medical bionics Market– Forces
4.1. Drivers
4.1.1. Technological advancement in healthcare
4.1.2. Increasing cases of organ failure
4.2. Restraints
4.3. Opportunities
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Artificial vital organs & medical bionics Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Artificial vital organs & medical bionics Market, By Product
6.1. Artificial Vital Organs Market
6.1.1. Artificial Heart
6.1.1.1. Total Artificial Heart (TAH)
6.1.2. Artificial Kidney
6.1.2.1. Hemodialysis Machines
6.1.3. Artificial Liver
6.1.4. Artificial Pancreas
6.1.4.1. Insulin Pumps
6.1.5. Artificial Lungs
6.1.5.1. Heart-Lung Bypass Machines
6.1.5.2. Oxygenators
6.2. Bionics Market
6.2.1. Ear Bionics (Cochlear Implants)
6.2.2. Vision Bionics
6.2.3. Exoskeletons
6.2.4. Bionic Limbs
6.2.4.1. Bionic Leg
6.2.4.2. Bionic Hand
6.2.5. Brain Bionics
6.2.5.1. Spinal Cord Stimulators
6.2.5.2. Deep Brain Stimulators
6.2.5.3. Vagus Nerve Stimulators
6.2.6. Cardiac Bionics
6.2.6.1. Ventricular Assist Device (VAD)
6.2.6.2. Left Ventricular Assist Device (LVAD)
6.2.6.3. Right Ventricular Assist Device (RVAD)
6.2.7. Heart Valves
6.2.7.1. Mechanical Heart Valves
6.2.7.2. Biological Tissue Valves
6.2.7.3. Transcatheter Heart Valves

7. Artificial vital organs & medical bionics Market, By Geography
7.1. Europe
7.1.1. Germany
7.1.2. France
7.1.3. Italy
7.1.4. Spain
7.1.5. Russia
7.1.6. U.K.
7.1.7. Rest of Europe
7.2. Asia Pacific
7.2.1. China
7.2.2. India
7.2.3. Japan
7.2.4. South Korea
7.2.5. Rest of Asia-Pacific
7.3. North America
7.3.1. U.S.
7.3.2. Canada
7.3.3. Mexico
7.4. Rest of the World (RoW)
7.4.1. Brazil
7.4.2. Rest of RoW

8. Artificial vital organs & medical bionics Market – Entropy
8.1. Expansion
8.2. Technological Developments
8.3. Merger & Acquisitions, and Joint Ventures
8.4. Supply- Contract

9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
9.1. Abbott Diabetes Care, Inc.
9.2. Abiomed, Inc.
9.3. Asahi Kasei Medical Co., Ltd.
9.4. Baxter International, Inc.
9.5. Cyberonics, Inc
9.6. Edwards Lifesciences Corporation
9.7. Ekso Bionics
9.8. F. Hoffmann-La Roche Ltd
9.9. Fresenius Medical Care AG & Co. Kgaa
9.10. Gambro AB
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

10. Appendix
10.1. Abbreviations
10.2. Sources
10.3. Research Methodology
10.4. Bibliography
10.5. Compilation of Expert Insights
10.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll